More on VKTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $26.71 |
|
|||
| Open | $26.83 | ||||
| 52 Wk High | $5.17 | ||||
| 52 Wk Low | $0.94 | ||||
| Day High | $27.29 | ||||
| Day Low | $26.34 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,583,440 | ||||
- Viking Therapeutic (VKTX) PT Lowered to $106 at Canaccord
- UBS Starts Viking Therapeutic (VKTX) at Buy
- Viking Therapeutics starts Phase 3 trials for oral obesity drug VK2735
- Viking Therapeutics Announces Initiation of VK2735 Oral Phase 3 Clinical Program in Patients with Obesity
- Viking Therapeutic (VKTX) PT Lowered to $85 at Truist Securities
- Viking Therapeutics starts oral VK2735 maintenance dosing trial
- Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity
- Form 8-K Viking Therapeutics, For: Sep 23
- Viking Therapeutics raises $575M through stock and note offerings
- Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Co
Entities mentioned with vktx
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- FDA | View Related Stories »
- William Blair | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
